Clinical Trials Directory

Trials / Unknown

UnknownNCT00000348

Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13

Infusion Laboratory: Protocol 4 (Dihydrexidine)

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate safety issues pertaining to dihydrexidine (DHX), to cocaine, and to its interaction, and to determine how pretreatment with DHX modifies the subjective as well as physiological effects of cocaine infusion.

Conditions

Interventions

TypeNameDescription
DRUGDihydrexidine

Timeline

First posted
1999-09-21
Last updated
2017-01-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000348. Inclusion in this directory is not an endorsement.

Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13 (NCT00000348) · Clinical Trials Directory